Literature DB >> 15907549

Regression of skin lesions of Kyrle's disease with clindamycin: implications for an infectious component in the etiology of the disease.

Sofia K Kasiakou1, George Peppas, Anastasios M Kapaskelis, Matthew E Falagas.   

Abstract

We report our experience with the management of a 44-year-old man with manifestations of Kyrle's disease. The patient presented to us with skin lesions of two different types. The old lesions were large hyperkeratotic plaques with burrows without signs of inflammation. The newer lesions were also hyperkeratotic plaques but they clearly had signs of inflammation. The patient was successfully managed with combined surgical and medical management; removal of the large hyperkeratotic skin lesions combined with administration of clindamycin, which led to regression of the smaller skin lesions. The regression of the lesions of the initial stage of Kyrle's disease with clindamycin suggests that infectious agents (probably anaerobic bacteria) may play a role in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907549     DOI: 10.1016/j.jinf.2004.06.009

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  4 in total

1.  Kyrle's disease in a patient of diabetes mellitus and chronic renal failure on dialysis.

Authors:  Pragya A Nair; Nidhi B Jivani; Nilofar G Diwan
Journal:  J Family Med Prim Care       Date:  2015 Apr-Jun

2.  Generalized Lesions of Kyrle's Disease: A Rare Case.

Authors:  Hartati Purbo Dharmadji; Chaerani Pratiwi Firdaus; Unwati Sugiri; Eva Krishna Sutedja; Pati Aji Achdiat; Laila Tsaqilah; Hendra Gunawan
Journal:  Int Med Case Rep J       Date:  2022-04-12

3.  Rare presentation of Kyrle's disease in siblings.

Authors:  Seethalakshmi Viswanathan; Swati D Narurkar; Aruna Rajpal; N G Nagpur; S S Avasare
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

4.  Tacalcitol in the treatment of acquired perforating collagenosis.

Authors:  J C Escribano-Stablé; C Doménech; J Matarredona; J C Pascual; A Jaen; J Vicente
Journal:  Case Rep Dermatol       Date:  2014-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.